Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones can decrease the ability of immune cells to fight bacteria.

Dutasteride is approved to help manage prostate enlargement.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

Finasteride, a drug that prevents testosterone conversion, can effectively reduce blood loss in prostate surgery, especially for patients with a prostatic volume over 30 cc, and decrease post-surgery complications.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Sebocytes play a key role in controlling androgen levels in human skin.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Doping in football faces legal challenges with testosterone limits, hair loss treatments, and recreational drug use.

Finasteride treatment can decrease certain steroids and increase others, possibly leading to depression symptoms in some cases.

Androgen increases VEGF expression but not VEGFR-2 in rat corpus cavernous.

Licorice extract helps hair growth and may treat hair loss.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

The microneedle patch boosts hair growth by reducing DHT and oxidative stress.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Finasteride increases hair count in men with hair loss, but the effect isn't permanent and hair loss returns if treatment stops.

Finasteride treats baldness but may cause lasting sexual side effects.

Finasteride affects the male rat brain by reducing certain protein activation, but these effects may reverse after stopping the drug.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.